Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

The front entrance to the Kennedy Institute

The Kennedy Institute of Rheumatology was delighted to receive two awards from the Oxford Preservation Trust, which celebrates the contribution that buildings and environmental projects make to the city’s character. The new roof extension won the 2021 Green Award for Sustainability as well as being awarded a Certificate in the New Building category.

It was designed by Fathom Architects to target ambitious PassivHaus EnerPHit standards and included designing for airtightness, minimizing thermal bridging and the use of triple glazing.

One of the key considerations was the energy efficiency of the building. To minimise the impact of cooling, glazing was replaced by fixed panels, external louvres and internal blinds. Insulation was added behind the non-transparent parts of the wall to improve its thermal performance. The roof has also been future-proofed with the structure designed to accommodate photo voltaic panels to be installed at a later stage.

The features were incorporated while maintaining the aesthetic of the original building.

Chairman of the Awards Panel, The Rev Prof William Whyte remarked that the sustainability standards reached were an “extraordinarily difficult thing to do with laboratories.”

Read more about the new roof extension.

Similar stories

The Kennedy Institute launches its single cell facility

We spoke to Irina Udalova and Stephen Sansom about the Kennedy’s new single cell facility and how it will enhance research at the Institute and beyond.

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

The Kennedy’s research strongly endorsed following independent review

We recently welcomed our Scientific Advisory Board (SAB) and the Kennedy Trust Scientific Review Board (TSRB) to the Institute to review our current activities and future plans.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.